• Info
  • Insider Trading

Insider Transactions Reported by 17 Insiders of Epizyme, Inc.

Location
Cambridge, MA

There are no Buy or Sell transactions made by insiders since 03 Mar 2025

Epizyme, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Pharma Investments 2019 ICAV Royalty Director, 10%+ Owner $31,960,000 31 Jan 2022
Matthew Ros Executive Vice President, Chief Strategy & Business Officer $156,951 16 Aug 2021
Andrew R. Allen Director $28,990 11 Jun 2021
Kevin T. Conroy Director 12 Aug 2022
Shefali Agarwal Consultant and Named Executive Officer 12 Aug 2022
Pablo G. Legorreta Director, 10%+ Owner 12 Aug 2022
Grant C. Bogle President and CEO, Director 12 Aug 2022
Michael F. Giordano Director 12 Aug 2022
Jerald Korn Chief Operating Officer 12 Aug 2022
Joseph Beaulieu Senior Vice President, Finance and Corporate Controller 12 Aug 2022
Jeffery Kutok Chief Scientific Officer 12 Aug 2022
Carol Stuckley Director 12 Aug 2022
ROY A. BEVERIDGE Director 12 Aug 2022
KENNETH BATE Director 12 Aug 2022
Victoria Richon Director 12 Aug 2022
David Mott Director 12 Aug 2022
CARL GOLDFISCHER Director 12 Aug 2022

Recent Insider Transactions by Companies or Individuals for Epizyme, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.